Roflumilast
SIGMA/SML1099 - ≥98% (HPLC)
Synonym: 3-
CAS Number: 162401-32-3
Empirical Formula (Hill Notation): C17H14Cl2F2N2O3
Molecular Weight: 403.21
MDL Number: MFCD00938270
Linear Formula: C17H14Cl2F2N2O3
Product Type: Chemical
assay | ≥98% (HPLC) |
color | white to beige |
form | powder |
InChI | 1S/C17H14Cl2F2N2O3/c18-11 |
InChI key | MNDBXUUTURYVHR-UHFFFAOYSA |
Quality Level | 100 |
SMILES string | ClC1=CN=CC(Cl)=C1NC(C2=CC |
solubility | DMSO: 20 mg/mL, clear |
storage temp. | −20°C |
Application: | Roflumilast has been used to evaluate its effect on acute lung inflammation and chronic lung changes in models of cigarette exposure in mice. It is also used to investigate its therapeutic potential to ameliorate primary blast-induced deficits in long-term potentiation (LTP). |
Biochem/physiol Actions: | Roflumilast is a highly potent, orally active, and selective phosphodiesterase 4 (PDE4) inhibitor with an IC50 of 0.8 nM. Roflumilast has anti-inflammatory properties and is used clinically to treat COPD. |
Features and Benefits: | This compound is a featured product for Cyclic Nucleotide research. Click here to discover more featured Cyclic Nucleotide products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
Packaging: | 10, 50 mg in glass bottle |
Symbol | GHS07 |
Signal word | Warning |
Hazard statements | H315 - H319 - H335 |
Precautionary statements | P302 + P352 - P305 + P351 + P338 |
Hazard Codes | Xi |
Risk Statements | 36/37/38 |
Safety Statements | 26 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
Storage Temp. | −20°C |
UNSPSC | 41106305 |